Rating agencies assess the creditworthiness of issuers and assign them what is known as a credit rating. The rating agencies talk regularly to the companies they rate to obtain information on their strategy and business planning. This information, together with the agencies’ own quantitative analyses, form the basis for their credit ratings. The ratings published by independent rating agencies help lenders assess the risk inherent in financial instruments. For companies seeking to raise funds in the capital markets by issuing bonds, commercial paper or other debt instruments a rating from two internationally recognised agencies is supportive.
For many years, Bayer has had its creditworthiness assessed by S&P Global Ratings and Moody’s. As a result of the agreed acquisition of Monsanto, both S&P Global Ratings and Moody’s are reviewing the possibility of a downgrade. Bayer continues to aim for an investment-grade credit rating after the successful closing of the Monsanto acquisition and is aiming for the single “A” rating category in the long term in order to offer bond investors a reliable and stable investment in a diversified global corporation.
Bayer is currently rated as follows:
|Rating agency||Long-term rating||Short-term rating|
|S&P Global Ratings||A-||A-2|
Recently, the rating agencies took the following rating actions:
May 20, 2016: S&P Global Ratings placed 'A-/A-2' ratings for Bayer on CreditWatch with negative outlook.
June 22, 2017: S&P Global Ratings affirms ‘A-2’ short-term rating, removing its CreditWatch for it.
May 24, 2016: Moody’s placed Bayer’s A3/P-2 ratings under review for downgrade.
The rating explicitly reflects an assessment of the potential risk that a company will not be able to meet the payment obligations relating to debt instruments it has issued (interest and repayment of the principal). The better the rating, the lower the risk is considered to be. Since lenders expect to receive higher interest payments in return for exposure to higher risks, a company with a very good credit rating other circumstances being equal can raise debt capital on more favorable terms than one with a lower rating. Each rating comes with an outlook, indicating to investors the direction in which the agency believes the rating might move in the future.
The analysts responsible for Bayer’s credit rating are:
|S&P Global Ratings||Maxime Puget|